Search

Search Constraints

You searched for: Author/Creator Reiberger, Thomas

Search Results

91. Revisiting liver disease progression in HIV/HCV‐coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. (26th June 2014)

92. Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. (18th February 2015)

94. Safety of direct oral anticoagulants in patients with advanced liver disease. (10th July 2021)

95. Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. Issue 6 (July 2019)

96. Short‐ and long‐term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma. Issue 6 (1st July 2019)

97. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats. Issue 10 (December 2020)

98. Soluble guanylyl cyclase stimulation and phosphodiesterase‐5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats. Issue 10 (12th January 2020)

99. Strategies for Assignment of HIV-HCV Genotype-1-Coinfected Patients to Either Dual-Therapy or Direct-Acting Antiviral Agent-Based Triple-Therapy. Issue 4 (May 2014)

100. Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease. (25th August 2022)